Why Biotechnology Investing is Looking Healthy

It has a greater emphasis on smaller companies that could help this equal-weight strategy outperform if there is increased M&A activity.

Click here to listen to the podcast.


Big Biotech ETF Bounce Looks for More Upside

Biotech ETFs Could Heat Up Thanks to Republican-Led Congress

Facing Obamacare Repeal, A Sturdy ETF Idea